NCT07160036View on ClinicalTrials.gov

Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapy

NARecruitingINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

September 20, 2025

Primary Completion Date

November 20, 2025

Study Completion Date

December 20, 2025

Conditions

Myopia

Interventions

DEVICE

RLRL(Model RS-200-2A, Eyerising; Suzhou Xuanjia Optoelectronic Technology Co., Ltd., Suzhou, China))

use RLRL twice a day

Trial Locations (1)

120120

RECRUITING

Tianjin Medical University Eye Hospital, Tianjin

All Listed Sponsors

collaborator

Tianjin Medical University Eye Hospital

OTHER

lead

Ruihua Wei

OTHER

NCT07160036 - Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapy | Biotech Hunter | Biotech Hunter